116 related articles for article (PubMed ID: 6870021)
1. Experimental Pseudomonas aeruginosa ulcerative keratitis model in the dog.
Wyman M; Swanson C; Kowalski JJ; Powers JD; Boraski EA
Am J Vet Res; 1983 Jun; 44(6):1135-40. PubMed ID: 6870021
[TBL] [Abstract][Full Text] [Related]
2. The immune system in experimental Pseudomonas keratitis. Model and early effects.
Twining SS; Lohr KM; Moulder JE
Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):507-15. PubMed ID: 3082789
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of experimental Pseudomonas keratitis in the guinea pig: bacteriologic, clinical, and microscopic observations.
Van Horn DL; Davis SD; Hyndiuk RA; Alpren TV
Invest Ophthalmol Vis Sci; 1978 Nov; 17(11):1076-86. PubMed ID: 100468
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
5. Experimental Pseudomonas keratitis in the rabbit: bacteriologic, clinical, and microscopic observations.
Van Horn DL; Davis SD; Hyndiuk RA; Pederson HJ
Invest Ophthalmol Vis Sci; 1981 Feb; 20(2):213-21. PubMed ID: 6780486
[TBL] [Abstract][Full Text] [Related]
6. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951
[TBL] [Abstract][Full Text] [Related]
7. Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits.
Onlen Y; Tamer C; Oksuz H; Duran N; Altug ME; Yakan S
Microbiol Res; 2007; 162(1):62-8. PubMed ID: 16904302
[TBL] [Abstract][Full Text] [Related]
8. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
[TBL] [Abstract][Full Text] [Related]
9. In vitro fluoroquinolone susceptibility of Pseudomonas aeruginosa isolates from dogs with ulcerative keratitis.
Ledbetter EC; Hendricks LM; Riis RC; Scarlett JM
Am J Vet Res; 2007 Jun; 68(6):638-42. PubMed ID: 17542697
[TBL] [Abstract][Full Text] [Related]
10. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model.
Cole N; Willcox MD; Fleiszig SM; Stapleton F; Bao B; Tout S; Husband A
Curr Eye Res; 1998 Jul; 17(7):730-5. PubMed ID: 9678419
[TBL] [Abstract][Full Text] [Related]
11. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
Karicherla P; Hobden JA
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas keratitis with satellite lesions: an unusual presentation.
Chaurasia S; Muralidhar R; Das S; Vaddavalli PK; Garg P; Gopinathan U
Br J Ophthalmol; 2010 Oct; 94(10):1409-10. PubMed ID: 20516141
[No Abstract] [Full Text] [Related]
13. Outbreak of ocular disease associated with naturally-acquired canine herpesvirus-1 infection in a closed domestic dog colony.
Ledbetter EC; Kim SG; Dubovi EJ
Vet Ophthalmol; 2009; 12(4):242-7. PubMed ID: 19604340
[TBL] [Abstract][Full Text] [Related]
14. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
Hazlett LD; McClellan S; Kwon B; Barrett R
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 is not critical to pathogenesis in a mouse model of Pseudomonas aeruginosa corneal infection.
Cole N; Hume E; Khan S; Krockenberger M; Thakur A; Husband AJ; Willcox MD
Curr Eye Res; 2005 Jul; 30(7):535-42. PubMed ID: 16020287
[TBL] [Abstract][Full Text] [Related]
16. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
[TBL] [Abstract][Full Text] [Related]
17. Association of CD4+ T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection.
Kwon B; Hazlett LD
J Immunol; 1997 Dec; 159(12):6283-90. PubMed ID: 9550433
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa corneal infection related to mascara applicator trauma--Georgia.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1990 Jan; 39(3):47-8. PubMed ID: 2104955
[No Abstract] [Full Text] [Related]
19. Lecithin-bound superoxide dismutase in the prevention of neutrophil-induced damage of corneal tissue.
Matsumoto K; Shimmura S; Goto E; Saito K; Takeuchi T; Miyajima S; Negi A; Tsubota K
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):30-5. PubMed ID: 9430542
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study on Pseudomonas keratitis in mice. 2. Clinical and histopathological investigation on experimental Pseudomonas keratitis in mice].
Tanaka N; Sasaki T; Ozeki T; Miyaji S; Kawano M
Nippon Ganka Gakkai Zasshi; 1972 Jul; 76(7):408-15. PubMed ID: 4628845
[No Abstract] [Full Text] [Related]
[Next] [New Search]
